Table 1.
Clinico-pathological characteristics of the patients
| Patient characteristics | Number of cases | Percentage (%) |
|---|---|---|
| Gender | ||
| Male | 31 | 62 |
| Female | 19 | 38 |
| Age (years): 57.6 ± 1.2 | ||
| Fuhrman grade | ||
| 1 | 2 | 4 |
| 2 | 4 | 8 |
| 3 | 30 | 60 |
| 4 | 14 | 28 |
| Tumour size (cm): 9.8 ± 0.5 | ||
| Tumour stage at diagnosis | ||
| T1 | 5 | 10 |
| T2 | 3 | 6 |
| T3 | 42 | 84 |
| MSKCC classification | ||
| Favourable | 11 | 22 |
| Intermediate | 32 | 64 |
| Poor | 7 | 14 |
| Immunotherapy before Sutent | 25 | 50 |
| Treatment response at 3 months | ||
| Partial response | 15 | 30 |
| Stable disease | 18 | 36 |
| Failure | 17 | 34 |
| Progression-free survival (months) | ||
| Partial response 20 ± 3 | ||
| Stable disease 19 ± 2 | ||
| Failure 4.1 ± 0.3 | ||
MSKCC: Memorial Sloan-Kettering Cancer Center.